Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis

NCT00222222 is registered in ClinicalTrials.gov with Universitätsmedizin Mannheim as lead sponsor.

NCT NCT00222222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00222222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
Lead sponsor
Universitätsmedizin Mannheim
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2003
Completion date
December 31, 2011
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis